Liver cancer treatment with targeted therapy

Targeted therapy is a type of cancer treatment that targets specific molecules or proteins involved in the growth and spread of cancer cells. Targeted therapies can be used to treat liver cancer alone or in combination with other treatments, such as chemotherapy or surgery. One type of targeted therapy used to treat liver cancer is called tyrosine kinase inhibitors (TKIs). Another type of targeted therapy used to treat liver cancer is called monoclonal antibodies. Monoclonal antibodies are proteins designed to recognize and bind to specific proteins on the surface of cancer cells. The steps of targeted therapy for liver cancer can vary depending on the specific targeted therapy used and the individual's specific situation. However, some general steps are to receive a diagnosis, determine the stage of liver cancer, make the most appropriate treatment plan, perform the targeted therapy treatment, and monitor the effectiveness. The potential benefits of targeted therapy for liver cancer have increased effectiveness, decreased side effects, improved quality of life, and potentially more prolonged survival. A doctor may adjust the treatment plan if the targeted therapy is not working as expected. Targeted therapy for liver cancer is just one aspect of a comprehensive treatment plan.